Engineered Host Cell Biotransformation for Opiate Alkaloid Supply
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The demand for opiate and opioid alkaloids exceeds natural supply, and existing methods for their extraction from poppy plants are inefficient and costly, necessitating chemical synthesis.
Innovation Solution
A biotransformation process using host cells transformed with nucleic acid molecules encoding enzymes for converting opiate alkaloids into further alkaloids, combined with optional extraction of the reaction products, including the use of modified polypeptides with altered activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis is used to produce opiate alkaloids, then production capacity can be increased to meet demand, but manufacturing cost increases and process complexity increases
Solution Approach 1:
The patent replaces chemical synthesis methods with biological catalysis using engineered enzymes. Host cells are transformed with nucleic acid molecules encoding enzymes that catalyze the conversion of opiate alkaloids, substituting chemical reaction processes with biologically-mediated transformations. This approach maintains high productivity while reducing manufacturing costs and complexity associated with chemical synthesis.
Solution Approach 2:
The patent introduces host cells as intermediary systems that perform the transformation of opiate alkaloids. These host cells, containing engineered enzymatic pathways, act as biological mediators that convert precursor compounds into target opiate alkaloids, replacing direct chemical synthesis routes and enabling scalable production with reduced operational complexity.
2Productivity
If chemical synthesis is used to produce opiate alkaloids, then production capacity can be increased to meet demand, but device complexity and process complexity increase
Solution Approach 1:
The patent replaces complex chemical synthesis processes with biological transformation systems. Engineered host cells perform multiple enzymatic reactions in sequence, converting precursors to target alkaloids through coordinated action of multiple enzymes. This biological system simplifies the overall process complexity while maintaining high production capacity.
Solution Approach 2:
The patent creates host cells with multi-functional enzymatic pathways that can produce multiple opiate alkaloids from common precursors. The engineered biological system performs various transformations (demethylation, hydroxylation, etc.) using different enzymes within the same host cell system, reducing the need for separate process lines and equipment for each alkaloid production.
3Reliability
If traditional extraction from poppy plants is used, then natural production is maintained, but productivity is insufficient to meet demand and manufacturing cost increases
Solution Approach 1:
The patent creates artificial biological systems that copy and enhance the natural opiate alkaloid production pathways. Host cells are engineered with nucleic acid molecules encoding enzymes that replicate the biosynthetic pathways found in poppy plants, but with improved efficiency and scalability. This allows production to exceed natural supply limits while maintaining the reliability of biological production systems.
Solution Approach 2:
The patent modifies key parameters of the production system by engineering host cells with optimized enzymatic pathways. Through genetic transformation and enzyme engineering, the system achieves higher conversion rates, improved yield, and enhanced productivity compared to traditional plant extraction, while maintaining the advantages of biological production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the production of opiate and opioid alkaloids, providing a scalable and efficient alternative to traditional extraction methods, addressing the supply-demand imbalance and reducing reliance on chemical synthesis.
Implementation Method 1
the codeine 3-O-demethylase (CODM) converts codeine into morphine through de-methylation
Data Source
AI summary
The disclosure relates to a biotransformation for the manufacture of one or more opiate or opioid alkaloids using a crude poppy extract or a purified or semi-purified source of opiate or opioid alkaloid; vectors comprising nucleic acid molecules encoding enzymes; microbial cells expressing nucleic acids encoding said enzymes and including modified enzymes with enhanced activity.